| 產(chǎn)品編號(hào) | bsk11036 |
| 英文名稱 | Human CXCL10/IP10 ELISA Kit |
| 中文名稱 | 人趨化因子CXCL10酶聯(lián)免疫試劑盒 |
| 別 名 | Chemokine (C X C motif) ligand 10; Chemokine CXC motif ligand 10; Crg 2; CRG2; CXCL 10; CXCL10; Gamma IP10; gIP 10; GIP10; IFI 10; IFI10; INP 10; INP10; Interferon activated gene 10; Interferon gamma induced cell line; Interferon inducible cytokine IP 10; MOB1; SCYB 10; SCYB10; Small inducible cytokine B10; Small inducible cytokine B10 precursor; Small inducible cytokine subfamily B (Cys X Cys) member 10; Gamma-IP-10. |
 |
Specific References (2) | bsk11036 has been referenced in 2 publications.
[IF=17.521] Lizhen He. et al. Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Advanced Science. 2023 Jan;:2202519 ELISA ; Human.
[IF=8.469] Zhang, Jie. et al. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. CELL DEATH DIS. 2022 Apr;13(4):1-14 ELISA ; Human.
|
| 克 隆 號(hào) | |
| 種 屬 | Human |
| 線性范圍 | 31.25 - 2,000 pg/mL |
| 應(yīng)用范圍 | S/P/CC |
| 檢測(cè)限 | 15 pg/mL |
| 適用樣品基質(zhì) | cell culture supernates, serum, and plasma. |
| 保存條件 | Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Shipped with wet ice.). |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Interferon-gamma-inducible 10 kD protein (IP-10), is a CXC chemokine with chemoattractant properties for CD4-positive T cells and inhibits early normal and leukemic hemopoietic progenitor proliferation. IP-10 is produced by a wide variety of cell types ranging from neutrophils and monocytes to hepatocytes, endothelial cells and keratinocytes. The cytokine is reported to be involved in a scala of inflammatory pathologies such as HIV encephalitis, cutaneous T cell lymphoma, chronic hepatitis and acute anterior uveitis. Various observations strongly suggest a role for the CXC chemokines IL-8 and IP-10 in the regulation of angiogenic activity in cancer and in idiopathic pulmonary fibrosis. |
